GlassScriptPhysician profile
Angela L Schuff
NPI 1407816457
$4,365.18
in general payments reported to CMS, 2019-2025
34 companies · $935 in 2025
The $935 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $163 · 2021: $447 · 2022: $822 · 2023: $675 · 2024: $542 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,367.02 | 2019-2025 | Ortholoc 2 Lapifuse, Citrefix, Viaflow |
| Medtronic, INC. | $329.71 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Musculoskeletal Transplant Foundation INC. | $306.58 | 2019 | |
| Organogenesis INC. | $299.48 | 2019-2024 | Cygnus Dual |
| Zimmer Biomet Holdings, INC. | $237.46 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $236.25 | 2021-2025 | Nuzyra |
| Pylant Medical | $199.56 | 2022 | |
| Trice Medical, INC. | $165.30 | 2023 | |
| Tenex Health INC. | $153.96 | 2021 | |
| Smith+Nephew, INC. | $113.63 | 2019-2025 | Collagenase Santyl, Grafix |
| Comsort, INC | $100.00 | 2019 | |
| Alfasigma USA, INC. | $89.88 | 2022 | |
| Nabriva Therapeutics, Plc | $82.69 | 2021-2022 | |
| Horizon Therapeutics Plc | $81.61 | 2022-2023 | Krystexxa |
| Globus Medical, INC. | $73.52 | 2025 | Senza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Orthopedics INC | $48.67 | 2023 | |
| Bioventus LLC | $48.29 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $44.17 | 2024-2025 | N/A, Motoband |
| Ani Pharmaceuticals, INC. | $43.22 | 2025 | Purified Cortrophin Gel |
| Nevro Corp. | $39.69 | 2022-2024 | Senza |
| Merck Sharp & Dohme LLC | $38.03 | 2019 | |
| In2bones USA, LLC | $35.17 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.01 | 2022-2023 | Jublia |
| Integra Lifesciences Corporation | $24.80 | 2020 | |
| Acera Surgical, INC. | $23.43 | 2022 | |
| Convatec INC. | $21.31 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $19.66 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.00 | 2023 | Seglentis |
| Wright Medical Technology, INC. | $17.37 | 2019 | |
| Amgen INC. | $16.00 | 2024 | Krystexxa |
| Kerecis Limited | $15.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Arteriocyte Medical Systems, INC. | $15.22 | 2019 | |
| Melinta Therapeutics, LLC | $12.72 | 2019 | |
| Next Science LLC | $12.39 | 2023 | Xperience, Blastx, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Schuff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.